Abstract
The anteroventral cochlear nucleus (AVCN) acts as the first relay center in the conduction of auditory information from the ear to the brain, and it probably performs a crucial role in sound localization. Auditory nerve input to the principal neurons of the AVCN, the spherical bushy cells, appears to be mediated by an excitatory amino acid such as glutamate, which acts at a specialized, large synaptic ending called an endbulb of Held. Presumably, endbulb synapses contain some specific combination of glutamate receptors to facilitate rapid neurotransmission of auditory signals. AMPA glutamate receptor composition at the endbulb synapses was examined with both light and electron microscope immunocytochemistry. Electron microscope localization of AMPA receptors was examined with two techniques, preembedding immunoperoxidase and postembedding immunogold, which provide maximum sensitivity and greatest accuracy, respectively. Dense and frequent labeling was seen with the AMPA receptor subunit antibodies GluR2/3 and GluR4, which were colocalized at the endbulb synapses. In contrast, immunolabeling with antibody to GluR2 was low. These data indicate that the major glutamate receptor at this synapse is an AMPA receptor made up mainly of GluR3 and GluR4 subunits. Receptors composed of these subunits display properties, such as calcium permeability and rapid desensitization, that facilitate their specialized functions in auditory information processing.
The spherical bushy cells of the anteroventral cochlear nucleus (AVCN) receive a direct input from the auditory nerve via a specialized synaptic contact called the endbulb of Held (for review, see Cant, 1992). This endbulb exhibits unique structural and functional specializations used in the initial processing of auditory information in the CNS that are necessary for sound localization and analysis. The endbulb is an enlarged calyx-type terminal that surrounds the bushy cell soma, contains large round vesicles, and forms multiple synaptic contacts with the soma. In addition, the endbulb forms attachment plaques with the soma and forms synapses with dendrites along the endbulb surface, opposite the side of the endbulb that contacts the bushy cell soma. The endbulb provides a secure, excitatory synaptic connection between the auditory nerve fiber and the spherical bushy cell soma; this permits the spherical bushy cell to show a primary-like response almost identical to the response of the auditory nerve (for review, see Rhode and Greenberg, 1992). This allows an auditory spike stream to pass, virtually unchanged, from the auditory nerve to the superior olivary complex (SOC) via the AVCN. Thus, the frequency information of the temporal discharge of the auditory nerve is preserved; this probably is important for the binaural mechanism for sound localization. In addition to the auditory input via the endbulb of Held, the spherical bushy cell receives inputs from other nuclei, including tuberculoventral cells of the deep dorsal cochlear nucleus, a few interneurons of the ventral cochlear nucleus, the contralateral cochlear nucleus, and the SOC (Wenthold and Hunter, 1990; Wickesberg et al., 1994; Juiz et al., 1996a,b; Yao et al., 1996); presumably these other inputs are necessary to obtain the proper response pattern of the spherical bushy cell.
The spherical bushy cell auditory nerve–endbulb synapse is believed to be glutamatergic (for review, see Wenthold et al., 1993; Hackney et al., 1996). Spherical bushy cells contain mRNA for AMPA receptors (Hunter et al., 1993). Also, preliminary studies have indicated the presence of AMPA and other glutamate receptors (NMDA, kainate, delta, metabotropic) (Petralia and Wenthold, 1992; Hunter and Wenthold, 1994;Petralia et al., 1994a,b,c, 1996a, 1997a,b; Sato et al., 1995; for review, see Wenthold et al., 1993, 1997a,b). In the present study, we examined the endbulb synapses on spherical bushy cells of the dorsorostral AVCN to determine the kinds of AMPA receptors involved in endbulb neurotransmission. We used preembedding immunoperoxidase and postembedding immunogold in combination (Petralia et al., 1997a; Rubio and Wenthold, 1997) to show that the major glutamate receptors of the endbulb synapse are AMPA receptor complexes containing mainly GluR3 and GluR4, suggesting that most of these glutamate receptors are calcium permeable and exhibit a rapid response. The latter characteristics of AVCN endbulb synapses may be essential for sound localization.
MATERIALS AND METHODS
Antibody production, purification, and characterization. Details of antibody production, purification, and characterization have been described previously (Table1). GluR2/3 antibody also is called GluR2/3/4c because it recognizes the variant GluR4c (Gallo et al., 1992). Monoclonal and polyclonal antibodies to GluR2/3 generally produced similar distributions in the brain (Petralia and Wenthold, 1992; Petralia et al., 1996b, 1997a; Rubio and Wenthold, 1997).
Preembedding immunoperoxidase: tissue preparation. Young male Sprague Dawley rats (125–250 gm) were anesthetized and perfused transcardially as described previously (Petralia and Wenthold, 1992;Petralia et al., 1994a,b,c, 1996a,b, 1997a,b). The fixative was cold 4% paraformaldehyde in 0.12 m phosphate buffer, pH 7.2–7.3, with or without 0.1% glutaraldehyde; glutaraldehyde was added mainly for electron microscope studies. Brains were removed, fixed, and sectioned with a vibratome (Pelco DTK-3000W microslicer) at 50 μm. To minimize movements of the cochlear nuclei during sectioning, 1% agarose in PBS was sometimes used. Some vibratome sections were infiltrated with 30% sucrose in PBS, frozen using acetone cooled with dry ice, and stored at −80°C; these sections were thawed and rinsed in PBS.
All experiments at National Institutes of Health were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (National Institutes of Health Publication no. 85-23). All efforts were made to minimize animal suffering, to reduce the number of animals used, and to use alternatives to in vivo techniques. Animal protocols used in this study at National Institutes of Health were approved by the National Institute of Neurological Diseases and Stroke/National Institute on Deafness and Other Communication Disorders Animal Care and Use Committee.
Preembedding immunoperoxidase: immunocytochemistry. Sections were incubated in 10% normal goat serum (NGS) in PBS (blocking solution for polyclonal antibodies) for 1 hr and in primary antibody overnight at 4°C, and further processed with avidin–biotin–peroxidase (Vectastain kit; Vector Laboratories, Burlingame, CA) and 3′,3-diaminobenzidine tetrahydrochloride as described previously.
Sections used for electron microscopy were fixed in 1% osmium tetroxide, dehydrated, and embedded in Poly/BED 812 resin (Polysciences, Warrington, PA) as described previously (Petralia and Wenthold, 1992). Thin sections of ∼75 nm were cut from the edge of the 50 μm vibratome sections (i.e., perpendicular to the plane of the section), using an LKB Ultratome IV or Leica Reichert Ultracut S ultramicrotome, and examined without further staining in a JEOL JEM-100CX II transmission electron microscope at 60 kV. Most thin sections were taken from parasagittal vibratome sections from the lateral part of the AVCN; thin sections usually were cut perpendicular to the base of the AVCN and were from the rostral portion of the section.
Postembedding immunogold. The technique used in the present study has been described (Petralia et al., 1997a; Rubio and Wenthold, 1997; Wang et al., 1997) and is a modification of a technique published previously (Matsubara et al., 1996; Landsend et al., 1997). Male Wistar rats prepared in Norway were anesthetized and perfused as described in the last two studies, and male Sprague Dawley rats prepared at National Institutes of Health were anesthetized and perfused as described above for preembedding immunoperoxidase. The fixative that was used was 4% paraformaldehyde plus 0.5% glutaraldehyde. Washing and vibratomy were performed in phosphate buffer (0.1 m with/without 4% glucose). Tissue (300 μm sections or hand-cut pieces) was then cryoprotected using a series of 10, 20, and 30% glycerol (last step overnight) in 0.1 m phosphate buffer and was plunge-frozen in liquid propane in a Leica KF80 (Norway) or EM CPC (National Institutes of Health). Frozen tissue was immersed in 1.5% uranyl acetate in methanol at −90°C in a Leica AFS freeze-substitution instrument, infiltrated in Lowicryl HM 20 resin at −45°C, and polymerized with UV light (−45°C to 0°C). Thin sections were cut on an ultramicrotome as described for preembedding immunoperoxidase.
In some cases, immunolabeling was preceded by etching in sodium ethanolate, but usually this was not done. Then sections were incubated in 0.1% sodium borohydride + 50 mm glycine in Tris-buffered saline/0.1% Triton X-100 (TBST) for 10 min. Grids were incubated in blocking serum in TBST for 10 min (10% NGS in most cases; 2% human serum albumin in some cases). Then grids were incubated in primary antibody in serum/TBST for 2 hr, followed by washes in TBST, blocking in serum/TBST, and incubation in 1:20 immunogold (Amersham, Arlington Heights, IL) in serum/TBST plus 0.5% polyethylene glycol (20,000 molecular weight); 5, 10, or 15 nm immunogold particles were used for single labeling and 5 + 15 nm used for double labeling. After further washes, sections were dried and stained with 1% uranyl acetate and 0.3% lead citrate.
AVCN cytology. In the rat, large spherical bushy cells form the only major cell type of the rostral area of the AVCN and were designated as type c round cells (with large endbulbs) by Harrison and Irving (1965); these probably correspond to the large spherical cells of the cat (Osen, 1969; Webster, 1995). This area was designated as area III of the ventral cochlear nucleus by Harrison and Irving (1965). Just caudal to area III is area I, which contains spherical bushy cells known as type i round cells (with pale endbulbs) and type h large multipolar cells; the type i round cells probably correspond to the small spherical cells of the cat (Osen, 1969; Webster, 1995). The spherical cell axon projects via the trapezoid body to the ipsilateral lateral superior olive (LSO) and bilaterally to the medial superior olive (MSO) (Webster, 1995). The remainder of the AVCN (caudal and ventral areas) is part of area II and contains type g oval cells (with modified endbulbs) and some other cell types. Areas I and III together correspond to the anterior division or spherical cell area of the AVCN described in other animals (cat: Osen, 1969, Brawer et al., 1974, Cant and Morest, 1979a; chinchilla: Morest et al., 1990; guinea pig: Hackney et al., 1990; mouse: Webster and Trune, 1982; Bilak et al., 1996; rat:Webster, 1995). In addition to spherical bushy cells, the anterior division of the AVCN contains stellate cells, with the majority found in the more caudal (posterior) portion.
Areas surveyed. Ultrastructural studies were limited to the rostrodorsal region (i.e., spherical cell area) of the AVCN, so that all identified endbulb synapses are likely to be associated with spherical bushy cells.
In this study, neuronal staining refers to staining of the cell body, excluding the nucleus, and of major dendrites that were traced from the cell body, whereas neuropilar staining refers to staining of processes not traced to specific cell bodies and the unresolvable matrix between cells (Petralia and Wenthold, 1992; Petralia et al., 1994a,b; our unpublished data).
Coronal sections of the AVCN typically included sections from two to three levels from rostral to caudal (based on Paxinos and Watson, 1986) and were taken from the following numbers of animals: GluR1,n = 6; GluR2/3, n = 5; GluR4,n = 3; and PBS controls, n = 8. Parasagittal sections of the AVCN typically included sections from three to four levels from lateral to medial and were taken from the following numbers of sides/numbers of animals: GluR1, n= 33/25; GluR2, n = 10/10; GluR2/3, n = 23/19; GluR4, n = 30/18; and PBS controls,n = 50/38. For immunoperoxidase electron microscopy, thin sections were examined from parasagittal sections taken from the following numbers of animals: GluR1, n = 1; GluR2,n = 4; GluR2/3, n = 7; GluR4,n = 5; and PBS controls, n = 4.
For postembedding immunogold, thin sections were examined from one block from each of two animals for each antibody: GluR2, GluR2/3, and GluR4. In addition, four cells (GluR2/3 antibody) were examined in a series of up to 21 consecutive sections (with some missing sections). Within this series, a subseries of 13 sections was used to reconstruct part of the synaptic contact region of one large endbulb, to elucidate the shapes and positions of 26 synapse-active zones, and to determine the distribution of gold particles in these active zones. Sections used in these series were collected on formvar/carbon-coated single-slot grids (Electron Microscopy Sciences, Fort Washington, PA) and thus could only be labeled on one side of the section. Immunogold counts at synapses included all gold particles found in the synaptic cleft and postsynaptic density (Rubio and Wenthold, 1997). Synapse measurements were taken on 50,000× prints.
Controls. Controls included (1) immunoblot analyses of brain regions and peripheral organs (Wenthold et al., 1990, 1992; Petralia et al., 1997a), (2) controls in which PBS was substituted for the primary antibody (PBS controls), and (3) preadsorption controls in which each antibody was incubated with its corresponding peptide (Petralia and Wenthold, 1992; Petralia et al., 1997a). PBS controls were performed on some sections in every run of all experiments.
For immunogold, there were 10 control experiments (designated here as Experiments 1–10): (1) NGS/TBST only substituted for the primary antibody, along with one each of five different gold-labeled secondary antibodies—5 nm (control Experiment 1) and 10 nm (Experiment 2) goat anti-rabbit, and 5 (Experiment 3), 10 (Experiment 4), and 15 (Experiment 5) nm goat anti-mouse; (2) GluR4 primary antibody along with either 15 nm goat anti-mouse (Experiment 6), or 5 nm goat anti-rabbit + 15 nm goat anti-mouse (Experiment 7); and (3) GluR2/3 monoclonal primary antibody along with one each of three different secondary antibody combinations—5 nm goat anti-rabbit only (Experiment 8), 5 nm goat anti-rabbit + 15 nm goat anti-mouse (Experiment 9), and 5 nm goat anti-mouse + 15 nm goat anti-rabbit (Experiment 10).
This study combines two established methods (i.e., immunoperoxidase, immunogold) for immunocytochemical localization of glutamate receptors. Generally, similar results were obtained with the two methods, providing strong evidence that the described glutamate receptor distribution is real, as shown previously for other types of neurons (Petralia et al., 1997a; Rubio and Wenthold, 1997). Thus, this combined method can act as a control for method-based artifacts. For both techniques, concentrations of primary antibodies were selected to produce little or no background staining at light or electron microscope levels. Such background artifactual staining was examined in both control sections and within the experimental sections, in structures that are presumed not to contain glutamate receptors. Immunoperoxidase- and immunogold-labeled sections were considered acceptable if they showed little or no labeling inside the mitochondria and nucleus.
RESULTS
Light microscopy
Sagittal (Fig. 1) and coronal sections of the AVCN gave similar results for immunostaining with antibodies to the AMPA receptor subunits. There was little or no staining with GluR1 antibody, light staining with GluR2 antibody, moderate to moderately dense staining with GluR4 antibody, and moderately dense staining with antibody to GluR2/3. Staining with the latter two antibodies was prevalent in all regions [I, II, and III of Harrison (Harrison and Irving, 1965)] and was found in presumptive spherical cells (identified by their location, medium to large size, and round to ovoid shape), as well as in various types of multipolar neurons throughout the AVCN. GluR2/3 and GluR4 antibodies also produced many densely staining puncta in the neuropil of the AVCN, and GluR4 antibody stained numerous fine neuropilar processes.
Electron microscopy: identification of spherical cell synapses
This study was limited mostly to identified spherical cell synapses. Identification of spherical cells was based largely on the identification of endbulb synapses on the cell body, because the other major neurons of this region, the stellate or medium-sized multipolar cells, do not bear endbulbs (for review, see Cant, 1992). Endbulb synapses contain large round vesicles in a very large terminal that makes multiple, asymmetric synaptic contacts (active zones) with a large soma. Often, these active zones extend slightly into the presynaptic terminal; sometimes the postsynaptic membrane is found on the side of a short spine projecting into the endbulb. Attachment plaques are seen between the endbulb and the soma. Attachment plaques (term refers specifically to the individual densities) or puncta adherentia (term refers to the entire junctional complex) are identified by the large, similar pre- and postsynaptic densities, straight cell membranes, and widened cleft (in some cases, a thin, intermediate dense line can be seen in the middle of the cleft); these junctions have not been well studied and may include more than one morphological variant (Gulley et al., 1978; Cant and Morest, 1979b). In comparison, only the postsynaptic density is thick in the endbulb active zones. The endbulbs also form synapses with dendrites (i.e., on the side of the endbulb opposite that of the somal/endbulb synapse); in addition, synapses are formed with the base of the main dendrite projecting from the soma.
Criteria for positive identification of a spherical bushy cell were based on the presence of endbulbs, but also on cell shape and size. Rat spherical bushy cells are large and roughly oval in shape (Saldaña et al., 1988). The nuclear “cap” of Nissl, which is well defined in cat spherical bushy cells (Osen, 1969; Cant, 1981), tends to be poorly developed in guinea pigs (Hackney et al., 1990) and chinchillas (Morest et al., 1990) and was never distinct in our rat sections. Cells used in this study had at least one endbulb profile contacting the cell; identification was based on published descriptions and micrographs (Lenn and Reese, 1966; Gentschev and Sotelo, 1973; Cant and Morest, 1979b; Cant, 1981; Rees et al., 1985; Ryugo and Sento, 1991; Ryugo et al., 1996). All large round vesicle-containing synapses, on a soma having an identified endbulb profile, were considered to be portions of endbulb synapses, based on previous auditory nerve degeneration studies (Cant and Morest, 1979b; Cant, 1981).
Electron microscopy: immunoperoxidase
Little or no staining was seen with antibody to GluR1 in spherical cells. Staining with antibody to GluR2 was low in spherical cells. Low to moderate staining was seen in some postsynaptic membranes and densities at round vesicle synapses, including endbulb profiles (Fig.2). In contrast to GluR1 and GluR2 antibodies, antibodies to GluR2/3 and GluR4 produced substantial cytoplasmic staining in spherical cell bodies as well as in many dendrites throughout the adjacent neuropil. With antibody to GluR4, patches of staining often were particularly prevalent on Golgi complexes. Staining with antibodies to GluR2/3 and GluR4, in postsynaptic membranes and densities in active zones of round vesicle synapses including endbulbs, was common and ranged from light to dense (Fig. 2). However, unstained active zones were seen frequently at these synapses. Postsynaptic staining also was common in active zones of dendrites forming synapses with endbulbs (i.e., opposite the endbulb–spherical cell soma synapse).
Electron microscopy: immunogold
On the basis of the patterns of receptor distribution suggested by the immunoperoxidase studies, immunogold labeling was used to localize more accurately labeling for antibodies to GluR2, GluR2/3, and GluR4. Gold particles (10 nm) were associated with the active zones of round vesicle synapses, including endbulbs on spherical cell somas, using antibodies to GluR2/3 (Fig. 3) and GluR4 (Figs. 4, 5). Two or more gold particles were found at 86% (average, 4.28 gold particles per synapse, counting all gold particles and all endbulb synapses) (Table2) of individual synapses in sections labeled with antibody to GluR2/3 and at 71% (average, 2.37 gold particles per synapse) of individual synapses in sections labeled with antibody to GluR4. In comparison, immunogold labeling was uncommon at these active zones using antibody to GluR2 (9%; average, 0.40 gold particles per synapse). Immunogold labeling increased only slightly when the concentration of primary antibody was increased (from 1.33 μg/ml to 4 μg/ml) and the gold size reduced (from 10 nm to 5 nm) to maximize gold labeling (Table 2); the latter antibody concentration and gold size were identical to those used in a study of GluR2 immunolabeling in fusiform cell synapses of the dorsal cochlear nucleus, where substantial GluR2 labeling was found (Rubio and Wenthold, 1997). The gold particles seen at the endbulb synapses with the AMPA receptor antibodies usually were associated closely with the postsynaptic membrane. However, a few gold particles sometimes were found on the presynaptic side of these synapses with antibody to GluR4 (Fig. 5); presynaptic gold was seen only rarely with GluR2/3 or GluR2 (Fig. 3). Postsynaptic gold labeling also was common (50–60%) at active zones of synapses of dendrites forming contacts with endbulbs (i.e., on the side opposite that of the somal–endbulb synapse (Figs. 3, 5; Table 2). Sometimes gold-labeled synapses were found on short spines projecting from the soma into the endbulb (Fig. 5); rarely, these spines extended to the opposite surface of the endbulb (Fig. 3). Thus, we cannot rule out that some of the smaller dendrite processes, counted in this study, actually are somal projections (Cant and Morest, 1979b). Double labeling (15 nm + 5 nm gold) showed that GluR2/3 (monoclonal antibody) (Rubio and Wenthold, 1997) and GluR4 immunolabeling colocalized frequently at round vesicle synapses on spherical cell somas (Fig. 6; Table 3).
Reconstruction of endbulb active zone areas using a series of consecutive sections immunolabeled with antibody to GluR2/3 showed that gold particles could be concentrated centrally in the synapse in many cases and peripherally in some cases (Fig.7). It also showed that only a small population of synapses has no gold along the entire surface area of the active zone. This confirms that labeling for these AMPA receptor subunits is found in most synapse-active zones.
Tangential distribution of gold particles along the postsynaptic membrane for antibodies to GluR2, GluR2/3, and GluR4 was fairly even, with the majority of gold particles within the central three-quarters of the postsynaptic membrane (Fig. 8). These three histograms were based on the inclusion of all gold-containing synaptic active zones used in the study from Table 2. Two additional sets of three histograms also were prepared (not shown) using samples restricted to active zone profiles with a diameter of >250 and 300 nm, to avoid the inclusion of peripheral cuts through active zones (Landsend et al., 1997). These limits were based on the smallest active zones seen in the serial reconstruction (Fig.7g) at about 200 nm; by comparison, serial reconstructions through cat endbulbs show some active zones <200 nm (Ryugo et al., 1996) and within the range of the smallest active zone profiles used in our study. Distributions of gold particles seen in these histograms were similar overall to those seen in Figure 8.
Controls
Controls for immunoperoxidase labeling were negative using both light (Fig. 1) and electron microscopy. Gold particles were rare or absent in controls for immunogold labeling.
DISCUSSION
To our knowledge, this study provides the first morphological evidence for glutamate receptors on the postsynaptic membrane of auditory nerve–endbulb synapses on spherical bushy cells of the AVCN. Both preembedding immunoperoxidase and postembedding immunogold techniques showed that the major type of postsynaptic glutamate receptor of endbulbs is an AMPA receptor containing mainly GluR3 and GluR4 subunits. This suggests that endbulb AMPA receptors are calcium-permeable and desensitize rapidly; such characteristics may facilitate auditory neurotransmission. The immunogold technique showed that endbulb AMPA receptors are present at most synapse-active zones throughout the endbulb–soma contact zone and are distributed evenly along the postsynaptic membrane.
Expression and organization of AMPA receptors at endbulb synapses
AMPA receptors found postsynaptic to spherical cell–primary auditory terminals contain GluR3 and GluR4, but few may contain GluR2, and GluR1 may be absent or rare. Previous in situhybridization studies indicate that spherical cells contain (1) GluR2, GluR3, and GluR4, but not GluR1 mRNA; (2) low levels of GluR2 mRNA and moderate levels of GluR3 mRNA (GluR4 mRNA expression was not quantified); and (3) only one-fourth to one-fifth as much GluR2 mRNA as is found in fusiform cells of the dorsal cochlear nucleus or cerebellar Purkinje cells (Hunter et al., 1993). Light microscope immunoperoxidase studies have shown similar results for receptor protein levels. Based on the present study, along with an earlier general study of the brain including the cochlear nuclei (Petralia et al., 1997a), there is little or no staining in the AVCN with GluR1 antibody, low staining with GluR2 antibody, and moderate to dense staining with GluR2/3 and GluR4 antibodies (similar findings have been de- scribed in avian cochlear nuclei although GluR2 antibody was not used) (Levin et al., 1997), again suggesting that the major AMPA receptor subunits of the AVCN are GluR3 and GluR4. By comparison, both GluR2 and GluR2/3 antibodies produced substantial staining in the dorsal cochlear nucleus (Petralia et al., 1996b, 1997a), suggesting that GluR2 is more common in neurons of the dorsal cochlear nucleus than in neurons of the AVCN. In the present study, GluR2 immunogold labeling at endbulb synapses is about one-fifth (0.44 gold particles per synapse) of that found at two kinds of fusiform cell synapses (dorsal cochlear nucleus: 1.9 gold particles per synapse for auditory nerve synapses; 2.2 gold particles per synapse for parallel fiber synapses) (Rubio and Wenthold, 1997), using identical antibody concentrations and gold particle sizes. (Because only low levels of GluR2 immunolabeling are found throughout the AVCN, a direct comparison with synapses rich in GluR2 within the AVCN could not be made.) This ratio is remarkably similar to that obtained for mRNA, supporting the suggestion that GluR2 subunits are infrequent in spherical cells and spherical cell–endbulb synapses. Use of two concentrations of the GluR2 antibody provides further proof that a low GluR2/GluR3 ratio is a real phenomenon at endbulb synapses and that this antibody is labeling all available epitopes, i.e., the labeling intensity for GluR2 does not show a further increase after using higher antibody concentrations. Another alternative explanation for low immunolabeling with GluR2 antibody is that epitope accessibility is compromised because of interference by associated proteins. However, the only described AMPA receptor-associated protein, GRIP, appears to interact with the far C terminus of GluR2 (Dong et al., 1997), i.e., the site of epitopes for GluR2/3 antibody but not for GluR2 antibody (Petralia et al., 1997a).
The serial reconstruction of part of an endbulb showed a structure and a distribution of active zones similar to those described in the cat (Ryugo et al., 1996, 1997). AMPA receptors are found in most active zones of endbulbs and also are spread throughout each active zone–postsynaptic membrane. The overall even distribution of AMPA receptor subunits in the active zones was demonstrated using both serial reconstructions and linear tangential measurements along the individual section profiles and is consistent with findings in other studies of ionotropic glutamate receptors in the CNS (AMPA, Nusser et al., 1994; Baude et al., 1993, 1995; Bernard et al., 1997; delta,Landsend et al., 1997). Finally, the perpendicular distribution of immunogold particles in the synapse indicates a postsynaptic localization of AMPA receptors at the endbulb synapse, consistent with findings in other areas of the nervous system (Nusser et al., 1994;Baude et al., 1995; Bernard et al., 1997). Occasional presynaptic gold particles seen with GluR4 antibody is consistent with findings in other regions (Baude et al., 1995; Matsubara et al., 1996); however, this evidence for presynaptic GluR4 is preliminary and requires more detailed analysis in a future study.
AMPA receptor function at endbulb synapses
These data indicate that many endbulb–AMPA receptors may be composed of GluR3 + GluR4 and lack GluR2. Such AMPA receptors are calcium-permeable and show rapid desensitization (Jonas et al., 1994;Mosbacher et al., 1994; Geiger et al., 1995; Jonas and Burnashev, 1995). Calcium-permeable AMPA receptors are found in a number of cell types in the nervous system, and there is a close negative correlation between abundance of GluR2 and calcium-permeability in neurons (Geiger et al., 1995; Jonas and Burnashev, 1995; Seeburg, 1996; Petralia, 1997). Jonas et al. (1994), using patch clamping and single-cell PCR, found that nonpyramidal neocortical neurons have high calcium permeability and low GluR2 expression (a complete absence of GluR2 was rare), whereas pyramidal neurons have relatively low calcium permeability and high GluR2 expression. Geiger et al. (1995), using similar techniques, examined neurons from several brain regions and concluded that the calcium permeability of native AMPA receptors is inversely correlated with relative abundance of GluR2. In addition, for most types of neurons, their data are consistent with a model of a pentameric AMPA receptor in which a single GluR2 subunit is sufficient to produce heteromeric AMPA receptor complexes with low calcium permeability. Thus, neurons with only low levels of GluR2 (less than ∼25%, based on relative abundance of GluR2 compared with the total of all AMPA receptor subunits) produce mostly GluR2-lacking, calcium-permeable AMPA receptors, and produce few GluR2-containing, calcium-impermeable AMPA receptors (Jonas et al., 1994; Geiger et al., 1995; Jonas and Burnashev, 1995). Calcium-permeable AMPA receptors, presumably lacking GluR2, have been demonstrated in the avian cochlear nucleus (Otis et al., 1995; Zhou et al., 1995; Solum et al., 1997). AMPA receptors containing high levels of flop variants of GluR3 or GluR4 show rapid desensitization (Mosbacher et al., 1994). This allows rapid neurotransmission, as suggested for parts of the auditory system (Raman et al., 1994; Geiger et al., 1995). Rapid neurotransmission also may involve calcium entry through GluR2-lacking AMPA receptors; this could activate calcium-dependent potassium channels to facilitate termination of the excitatory postsynaptic potential (Geiger et al., 1995). A rapid response of spherical bushy cells to auditory nerve stimulation is expected, because these neurons are believed to act as relays of high-frequency information from the auditory nerve to other auditory centers (Isaacson and Walmsley, 1995). Rapid neurotransmission in the cochlear nucleus and other auditory nuclei may be necessary for accurate transmission of temporal signals involved in sound localization (Raman et al., 1994).
The high density of neurotransmitter release sites (i.e., active zones) and associated AMPA receptors at endbulb synapses may improve transmission of timing information (avian studies) (Trussell et al., 1993, Otis et al., 1996). Briefly, neurotransmitter release from multiple sites on endbulbs causes delayed clearance of neurotransmitter; this activates a steady potassium conductance that reduces the membrane time constant, thereby speeding and improving the precision of repetitive firing. This phenomenon also promotes desensitization, which may protect the cell from excessive calcium entry through these GluR2-lacking AMPA receptors.
Other receptors at endbulb synapses
Preliminary studies indicate that other types of glutamate receptors (kainate, delta, NMDA, metabotropic) exist only at low levels at endbulb synapses (one exception may be mGluR1α at synapses between dendrites and endbulbs) (Wang et al., 1996, 1997; our unpublished data). This suggests that either these receptors play only minimal roles at endbulb synapses (for NMDA receptors, see Wickesberg and Oertel, 1989; Isaacson and Walmsley, 1995), or uncommon receptors are sufficient for significant function (for metabotropic receptors, seeLachica et al., 1995).
Dendrite synapses
Differences in immunolabeling with AMPA receptors were seen between endbulb–bushy cell soma synapses and endbulb–dendrite synapses. In the AVCN anterior division, the latter dendrites are almost certainly derived from spherical bushy cells; most likely they are distal dendrites from cells other than the one forming the somal synapses with that particular endbulb (Cant and Morest, 1979a,b; Rees et al., 1985; Ryugo and Sento, 1991; Ryugo et al., 1996). Immunogold particles for GluR2/3 and GluR4 immunolabeling were less frequent in endbulb–dendrite synapses compared with endbulb–soma synapses. If these differences occur in the same population of spherical bushy cells, postsynaptic AMPA receptors would be differentially distributed in these cells. Differential distribution of glutamate receptors has been reported for other neurons (Petralia et al., 1994a; Landsend et al., 1997; Rubio and Wenthold, 1997; Zhao et al., 1997). This is consistent with the reduced cytoplasmic content of the distal dendrites of spherical bushy cells and the paucity of their synaptic contacts, and it supports suggestions that these dendrites play only a minor role in primary auditory neurotransmission (Cant and Morest, 1979b).
Footnotes
This study was supported by the National Institute on Deafness and Other Communication Disorders Intramural Research Program. We thank Dr. M. E. Rubio for many helpful suggestions; Dr. K. K. Osen for preparing some of the tissue used in the preliminary study and for helpful suggestions; A. S. Landsend, B. Riber, and K. M. Gujord for help and advice on the immunogold technique; Dr. J. Fex for reviewing this paper; and Dr. P. Streit for providing monoclonal GluR2/3.
Correspondence should be addressed to Ronald S. Petralia, National Institute on Deafness and Other Communication Disorders/National Institutes of Health, 36/5D08, 36 Convent Drive, MSC 4162, Bethesda, MD 20892-4162.